25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

被引：3
|
作者：
Michos, Erin D. [1 ]
Lutsey, Pamela L. [2 ]
机构：
[1] Johns Hopkins Univ, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21287 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
来源：
ATHEROSCLEROSIS | 2016年 / 245卷
关键词：
Commentary; Vitamin D; Hypertension; Coronary heart disease; Risk reclassification; PROTEIN GENE POLYMORPHISMS; VITAMIN-D DEFICIENCY; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; ASSOCIATION; COMMUNITIES; MORTALITY; RACE;
D O I：
10.1016/j.atherosclerosis.2015.11.035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [21] Serum 25-hydroxyvitamin D and the risk of ovarian cancer
    Toriola, Adetunji T.
    Surcel, Helja-Marja
    Agborsangaya, Calypse
    Grankvist, Kjell
    Tuohimaa, Pentti
    Toniolo, Paolo
    Lukanova, Annekatrin
    Pukkala, Eero
    Lehtinen, Matti
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (02) : 364 - 369
  • [22] Serum 25-Hydroxyvitamin D Concentration and Risk of Dementia
    Knekt, Paul
    Saaksjarvi, Katri
    Jarvinen, Ritva
    Marniemi, Jukka
    Mannisto, Satu
    Kanerva, Noora
    Heliovaara, Markku
    EPIDEMIOLOGY, 2014, 25 (06) : 799 - 804
  • [23] 25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification
    de Boer, Ian H.
    Kestenbaum, Bryan
    Shoben, Abigail B.
    Michos, Erin D.
    Sarnak, Mark J.
    Siscovick, David S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (08): : 1805 - 1812
  • [24] Independent assortment of GC gene polymorphism (rs2282679) and 25-hydroxyvitamin D levels in coronary artery disease
    Sedky, Nada K.
    Hassanein, Sally I.
    Gad, Mohamed Zakaria
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (04) : 345 - 351
  • [25] The mRNA Expression and Circulating Levels of Visfatin and Their Correlation with Coronary Artery Disease Severity and 25-Hydroxyvitamin D
    Fadaei, R.
    Parvaz, E.
    Emamgholipour, S.
    Moradi, N.
    Vatannejad, A.
    Najafi, M.
    Doosti, M.
    HORMONE AND METABOLIC RESEARCH, 2016, 48 (04) : 269 - 274
  • [26] 25-HYDROXYVITAMIN D LEVELS AND MORTALITY
    Schoettker, B.
    Mena, J. M. Ordonez
    Brenner, H.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 102 - 102
  • [27] 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
    Michos, Erin D.
    Selvin, Elizabeth
    Misialek, Jeffrey R.
    McEvoy, John W.
    Ndumele, Chiadi E.
    Folsom, Aaron R.
    Ballantyne, Christie M.
    Lutsey, Pamela L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (11):
  • [28] Association of 25-hydroxyvitamin D with anemia risk in patients scheduled for cardiac surgery
    Zittermann, Armin
    Kuhn, Joachim
    Dreier, Jens
    Knabbe, Cornelius
    Prokop, Sylvana
    Gummert, Jan F.
    Boergermann, Jochen
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (01) : 29 - 36
  • [29] 25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
    Melamed, Michal L.
    Astor, Brad
    Michos, Erin D.
    Hostetter, Thomas H.
    Powe, Neil R.
    Muntner, Paul
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12): : 2631 - 2639
  • [30] Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in China
    Lu, Yanhui
    Liu, Minyan
    Pei, Yu
    Li, Jian
    Tian, Hui
    Cheng, Xiaoling
    Fang, Fusheng
    Sun, Banruo
    Xiao, Haiying
    Li, Nan
    Miao, Xinyu
    Li, Chunlin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 13790 - 13796
12345